pF145 pAcGFP1 SOD1G93A Citations (5)
Originally described in: Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS).Stevens JC, Chia R, Hendriks WT, Bros-Facer V, van Minnen J, Martin JE, Jackson GS, Greensmith L, Schiavo G, Fisher EM PLoS One. 2010 . 5(3):e9541. PubMed Journal
Articles Citing pF145 pAcGFP1 SOD1G93A
| Articles |
|---|
| Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Yu A, Shibata Y, Shah B, Calamini B, Lo DC, Morimoto RI. Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):E1481-90. doi: 10.1073/pnas.1321811111. Epub 2014 Apr 1. PubMed |
| beta-catenin aggregation in models of ALS motor neurons: GSK3beta inhibition effect and neuronal differentiation. Pinto C, Medinas DB, Fuentes-Villalobos F, Maripillan J, Castro AF, Martinez AD, Osses N, Hetz C, Henriquez JP. Neurobiol Dis. 2019 Jun 7;130:104497. doi: 10.1016/j.nbd.2019.104497. PubMed |
| Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Joshi AU, Minhas PS, Liddelow SA, Haileselassie B, Andreasson KI, Dorn GW 2nd, Mochly-Rosen D. Nat Neurosci. 2019 Oct;22(10):1635-1648. doi: 10.1038/s41593-019-0486-0. Epub 2019 Sep 23. PubMed |
| Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model. Woo TG, Yoon MH, Kang SM, Park S, Cho JH, Hwang YJ, Ahn J, Jang H, Shin YJ, Jung EM, Ha NC, Kim BH, Kwon Y, Park BJ. Commun Biol. 2021 Dec 15;4(1):1397. doi: 10.1038/s42003-021-02862-z. PubMed |
| Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation. Liu X, Zhang J, Li J, Song C, Shi Y. Mol Metab. 2022 Sep;63:101536. doi: 10.1016/j.molmet.2022.101536. Epub 2022 Jun 28. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.